Equillium Inc (EQ)
0.6794
-0.10
(-12.94%)
USD |
NASDAQ |
Nov 14, 16:00
0.6794
0.00 (0.00%)
After-Hours: 18:07
Equillium Profit Margin (Quarterly): 3.38% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.38% |
| March 31, 2024 | -25.58% |
| December 31, 2023 | -25.43% |
| September 30, 2023 | -41.83% |
| Date | Value |
|---|---|
| June 30, 2023 | -36.64% |
| March 31, 2023 | -44.37% |
| December 31, 2022 | 17.60% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-44.37%
Minimum
Mar 2023
17.60%
Maximum
Dec 2022
-21.84%
Average
-25.58%
Median
Mar 2024
Profit Margin (Quarterly) Benchmarks
| Matinas BioPharma Holdings Inc | -- |
| Tenon Medical Inc | -424.6% |
| Alphatec Holdings Inc | -26.28% |
| Madrigal Pharmaceuticals Inc | -172.0% |
| Spero Therapeutics Inc | -296.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.49% |
| Return on Assets | -16.57% |
| Return on Invested Capital | -35.49% |
| Operating Margin (Quarterly) | -0.72% |
| Return on Net Operating Assets | -105.0% |